Antipsychotic drug ruling overturned
Thursday, March 20, 2014 - 13:41
in Mathematics & Economics
The Arkansas Supreme Court on Thursday overturned a $1.2 billion U.S. judgment against Johnson & Johnson in a lawsuit challenging the drugmaker's marketing of the antipsychotic drug Risperdal.